We are live on ! Find out more
MDCO

Medicines Co
MDCO

Delisted

MDCO was delisted on the 3rd of January, 2020.

Back to rankings

182 hedge funds and large institutions have $2.6B invested in Medicines Co in 2013 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 64 increasing their positions, 66 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 21

29% more call options, than puts

Call options by funds: $11.1M | Put options by funds: $8.59M

6% more capital invested

Capital invested by funds: $2.46B → $2.6B (+$148M)

6% more funds holding

Funds holding: 172 → 182 (+10)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

3% less repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 66

Holders
182
Holders Change
+10
Holders Change %
+5.81%
% of All Funds
5.28%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
32
Increased
64
Reduced
66
Closed
21
Calls
$11.1M
Puts
$8.59M
Net Calls
+$2.52M
Net Calls Change
-$10.6M

Top Buyers

Rank Fund Capital Flow
1
FCM
Frontier Capital Management
Massachusetts
+$32.2M
2
BM
Bridger Management
New York
+$22.5M
3
Neuberger Berman Group
Neuberger Berman Group
New York
+$16.2M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$14.9M
5
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$11.2M

Top Sellers

Rank Fund Capital Flow
1
PC
PointState Capital
New York
-$51.8M
2
ZDA
Zweig-DiMenna Associates
New York
-$21.6M
3
Citadel Advisors
Citadel Advisors
Florida
-$12.7M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$11.1M
5
PHS
PFM Health Sciences
California
-$8.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$20.3M -$4.88M -136,440 -21%
BA
27
BlackRock Advisors
Delaware
$19.2M -$3.4M -95,221 -16%
O
28
OppenheimerFunds
New York
$18.7M +$1.62M +45,170 +10%
TA
29
Teachers Advisors
New York
$18M +$105K +2,950 +0.6%
Neuberger Berman Group
30
Neuberger Berman Group
New York
$17.8M +$16.2M +452,990 +5,084%
Bank of Montreal
31
Bank of Montreal
Ontario, Canada
$15.3M +$2.96M +82,839 +27%
Norges Bank
32
Norges Bank
Norway
$15.2M – – –
Geode Capital Management
33
Geode Capital Management
Massachusetts
$14.8M +$2.72M +75,930 +25%
Public Employees Retirement Association of Colorado
34
Public Employees Retirement Association of Colorado
Colorado
$13.8M – – –
Goldman Sachs
35
Goldman Sachs
New York
$13.4M +$2.19M +61,210 +21%
Allianz Asset Management
36
Allianz Asset Management
Germany
$13M +$4M +111,885 +50%
TCIM
37
TIAA CREF Investment Management
New York
$12.6M +$295K +8,245 +3%
Loomis, Sayles & Company
38
Loomis, Sayles & Company
Massachusetts
$12.1M +$11.2M +312,695 New
SGA
39
Sector Gamma AS
Norway
$11.1M -$1.09M -30,500 -10%
WC
40
Wexford Capital
Florida
$10.1M -$6.93M -193,900 -42%
Ameriprise
41
Ameriprise
Minnesota
$9.79M +$477K +13,352 +6%
NCGI
42
Next Century Growth Investors
Minnesota
$9.11M +$8.43M +235,764 New
D.E. Shaw & Co
43
D.E. Shaw & Co
New York
$9.07M -$2.89M -80,779 -26%
Federated Hermes
44
Federated Hermes
Pennsylvania
$8.87M +$1.87M +52,195 +29%
Deutsche Bank
45
Deutsche Bank
Germany
$8.63M -$2.54M -71,043 -24%
PAM
46
Panagora Asset Management
Massachusetts
$8.31M -$202K -5,643 -3%
California Public Employees Retirement System
47
California Public Employees Retirement System
California
$8.22M +$143K +3,999 +2%
STC
48
SEI Trust Company
Pennsylvania
$8.21M +$4.77M +133,410 +168%
QBFM
49
QS Batterymarch Financial Management
New York
$8.09M -$371K -10,370 -5%
Morgan Stanley
50
Morgan Stanley
New York
$8.06M +$3.17M +88,685 +74%
1
2
3 4 5

MDCO Hedge Fund Activity: Q4 2013 in Review

182 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q4 2013, worth a combined $2.6B — up 6% from $2.46B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new MDCO positions and 21 closed out — a net gain of 11 holders — while 64 added to existing stakes and 66 trimmed.

The largest buyer was Frontier Capital Management, adding an estimated $32.2M. The largest seller was PointState Capital, cutting an estimated $51.8M.

  • 182 institutional investors held Medicines Co (MDCO) as of Q4 2013, up from 172 in Q3 2013.
  • Funds reported $2.6B of Medicines Co stock for Q4 2013, up 6% quarter-over-quarter.
  • 32 funds opened new Medicines Co positions in Q4 2013 and 21 closed out, a net change of +11 holders.
  • The largest Medicines Co buyer in Q4 2013 was Frontier Capital Management, an estimated $32.2M added.
  • The largest Medicines Co seller in Q4 2013 was PointState Capital, an estimated $51.8M sold.

Based on aggregated 13F filings for Q4 2013.